BRPI0507269A - compostos, tautÈmeros, estereoisÈmeros, pró-drogas e sais dos mesmos, composições farmacêuticas,e , uso de um composto - Google Patents

compostos, tautÈmeros, estereoisÈmeros, pró-drogas e sais dos mesmos, composições farmacêuticas,e , uso de um composto

Info

Publication number
BRPI0507269A
BRPI0507269A BRPI0507269-7A BRPI0507269A BRPI0507269A BR PI0507269 A BRPI0507269 A BR PI0507269A BR PI0507269 A BRPI0507269 A BR PI0507269A BR PI0507269 A BRPI0507269 A BR PI0507269A
Authority
BR
Brazil
Prior art keywords
compounds
pharmaceutical compositions
salts
compound
tautomers
Prior art date
Application number
BRPI0507269-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Josephus H M Lange
Cornelis G Kruse
Herman H Van Stuivenberg
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority claimed from PCT/EP2005/050680 external-priority patent/WO2005080345A2/en
Publication of BRPI0507269A publication Critical patent/BRPI0507269A/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0507269-7A 2004-02-19 2005-02-16 compostos, tautÈmeros, estereoisÈmeros, pró-drogas e sais dos mesmos, composições farmacêuticas,e , uso de um composto BRPI0507269A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04100656 2004-02-19
PCT/EP2005/050680 WO2005080345A2 (en) 2004-02-19 2005-02-16 Imidazoline derivatives having cb1-antagonistic activity

Publications (1)

Publication Number Publication Date
BRPI0507269A true BRPI0507269A (pt) 2007-06-26

Family

ID=34928876

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507269-7A BRPI0507269A (pt) 2004-02-19 2005-02-16 compostos, tautÈmeros, estereoisÈmeros, pró-drogas e sais dos mesmos, composições farmacêuticas,e , uso de um composto

Country Status (7)

Country Link
CN (1) CN101076520B (zh)
AR (1) AR047613A1 (zh)
BR (1) BRPI0507269A (zh)
SA (1) SA05260008B1 (zh)
TW (1) TWI335321B (zh)
UA (1) UA84737C2 (zh)
ZA (1) ZA200606123B (zh)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI231757B (en) * 2001-09-21 2005-05-01 Solvay Pharm Bv 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity
MXPA04002583A (es) * 2001-09-21 2004-06-18 Solvay Pharm Bv Derivados de 4,5-dihidro-1h-pirazol novedosos que tienen actividad antagonistica del canabinoide (cb1).
AR038966A1 (es) * 2002-03-18 2005-02-02 Solvay Pharm Bv Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof

Also Published As

Publication number Publication date
TWI335321B (en) 2011-01-01
AR047613A1 (es) 2006-01-25
SA05260008A (ar) 2005-12-03
CN101076520A (zh) 2007-11-21
UA84737C2 (ru) 2008-11-25
ZA200606123B (en) 2007-11-28
TW200530191A (en) 2005-09-16
CN101076520B (zh) 2011-06-01
SA05260008B1 (ar) 2007-10-29

Similar Documents

Publication Publication Date Title
MY155836A (en) Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
BRPI0610850A2 (pt) derivados de Ácido aril alquila, composiÇço farmacÊutica, medicamento, bem como uso dos referidos derivados
MY160357A (en) Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
HRP20050531B1 (hr) Novi aromatski derivati fluorglikozida, lijek koji sadrži te spojeve i njihova upotreba
CY1115058T1 (el) Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης
HRP20050532A2 (en) Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
BR0315580A (pt) Derivados de metileno uréia
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
BRPI0911404A2 (pt) Derivados de pirano, sua preparação e uso dos mesmos em perfumaria
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
BRPI0507321A (pt) derivados de 7-amino-4-quinolona-3-ácido carboxìlico substituìdos com cicloalquila, processos para produção dos mesmos e uso dos mesmos como medicamento
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
BRPI0607918A2 (pt) tetraidro-piridoazepin-8-onas e compostos relacionados para o tratemento da esquizofrenia.
UY30673A1 (es) Derivados 6, 7 y 8 sustituidos del acido (3r)-5-oxo-2,3-dihidro-5h-tiazolo[3,2a]piridin-3-carboxilico, composiciones farmacéuticas conteniéndolos y aplicaciones.
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
MX2009005242A (es) Derivados de 3-(hetero)arilisoquinolinamida sustituida en posición 5, 6 o 7 y uso terapeutico del mismo.
CO5690542A2 (es) Metodo para la produccion de derivados de acil-fenil-urea sustituidos por animo-carbonilo y el uso de los mismos
GT200500214A (es) Amidas del acido 5 y 6-aminoalquil indol-2-carboxilico 3-sustituidas y análogos relacionados como inhibidores de la caseína cinasa epsilon
BRPI0414494A (pt) compostos, composições farmacêuticas, e, uso de um composto
BRPI0414644A (pt) composto, composições farmacêuticas, e, uso de um composto
BRPI0507269A (pt) compostos, tautÈmeros, estereoisÈmeros, pró-drogas e sais dos mesmos, composições farmacêuticas,e , uso de um composto
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
GEP20115192B (en) Novel indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
MA33882B1 (fr) Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE, CONFORME ART. 10 DA RES. 124/06.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.